Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types

Abstract

This study provides evidence for the usefulness of HRD analysis in all cancer types, improves chemotherapy decision making and its efficacy in clinical settings, and represents a substantial advancement in precision oncology.